Biogen Idec

Biotech's Movers and Shakers 2009: BioBuzz
TheStreet.com
Mon, 01/4/10 - 09:38 am
Biogen Idec
Genzyme
Amgen
Gilead Sciences
Celgene
Vanda
Human Genome Sciences
Keryx
Opexa
CompuGen
Repros Therapeutics
Sequenom
GTx
GTC Biotherapeutics
Large-Cap Biotechs Face Familiar Problem
Yahoo/Investors Business Daily
Mon, 12/28/09 - 04:47 am
biotech
Amgen
Biogen Idec
Bristol-Myers Squibb
Roche
Genzyme
Gilead Sciences
Celgene
Facet Rebuffs Biogen: Will a White Knight Emerge?
Seeking Alpha
Mon, 12/21/09 - 10:06 am
Facet Biotech
M&A
Biogen Idec
Abbott Laboratories
Hedge Funds Help Scuttle Biogen’s Facet Bid
NY Times, NY
Fri, 12/18/09 - 10:43 am
Biogen Idec
M&A
Facet Biotech
hedge funds
Merck and J&J Land Deals; Biogen Idec, Not So Much
WSJ Online
Thu, 12/17/09 - 01:31 pm
Biogen Idec
Merck
JNJ
Facet Biotech
M&A
Biogen Threatens Proxy Over Rejected Bid for Facet
Bloomberg
Tue, 12/15/09 - 04:59 pm
Facet Biotech
Biogen Idec
M&A
Roche, Genentech and Biogen Idec announce positive results from first phase III trial of ocrelizumab
PR-Canada
Sun, 12/13/09 - 12:20 pm
Roche
Genentech
Biogen Idec
ocrelizumab
Facet rejects Biogen Idec offer
Bizjournals.com
Thu, 12/10/09 - 10:30 am
Facet Biotech
M&A
Biogen Idec
Biotechs to Watch in the Blood Business
Minyanville
Mon, 12/7/09 - 05:57 pm
ONYX Pharmaceuticals
Cephalon
Roche
Biogen Idec
Novartis
Incyte
Biogen Idec Blinks: Is It Enough for Facet Biotech, or Will the Drama Continue?
BNET Pharma
Mon, 12/7/09 - 12:49 pm
Facet Biotech
Biogen Idec
M&A
Our Final Offer (Maybe)! That's a FACT! (Biogen, Facet)
Motley Fool
Sat, 12/5/09 - 10:50 am
Biogen Idec
Facet Biotech
Facet Biotech Advises Stockholders to Take No Action in Response to Revised Biogen Idec Tender Offer
Yahoo
Thu, 12/3/09 - 07:29 pm
Biogen Idec
Facet Biotech
M&A
Biogen raises Facet offer to $17.50 per share
Yahoo/AP
Thu, 12/3/09 - 05:40 pm
Facet Biotech
Biogen Idec
M&A
Financing Drug Discovery: Recent Deals
Seeking Alpha
Fri, 11/27/09 - 11:21 am
Biogen Idec
drug discovery
Oxagen
Icahn Makes Big Moves in Healthcare Stocks
Yahoo/Indie Research
Mon, 11/23/09 - 09:36 am
Genzyme
Carl Icahn
Biogen Idec
Amylin
Genentech, Biogen Idec get FDA request on application for Rituxan's use in leukemia
Yahoo/AP
Thu, 11/19/09 - 07:52 am
Genentech
Roche
Biogen Idec
FDA
Rituxan
leukemia
Biogen Idec's Social Media Ties Save Tysabri Again; FDA Watching
BNET Pharma
Fri, 11/13/09 - 08:55 am
Biogen Idec
social media
FDA
Tysabri
MS
multiple sclerosis
When Rival Drug Makers Compare Notes On Safety Problems
WSJ Online
Wed, 11/11/09 - 05:57 pm
Elan
Biogen Idec
Roche
Tysabri
drug safety
Elan, Biogen change Tysabri label due to PML risk
Reuters
Mon, 11/9/09 - 10:07 am
Elan
Biogen Idec
Tysabri
PML
MS
Biogen's a Buy
Barron's
Tue, 11/3/09 - 09:19 am
Biogen Idec

Pages